Highly Efficient Regulation of Gene Expression by Tetracycline in a Replication-Defective Herpes Simplex Viral Vector

Molecular Therapy

Volumn 13, Issue 6, 2006, Pages 1133-1141

  Yao, Feng ^a   Theopold, Christoph ^a   Hoeller, Daniela ^a   Bleiziffer, Oliver ^a   Lu, Zheming ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

gene expression; gene transfer; HSV vector; tetR; tetracycline

Indexed keywords

BETA GALACTOSIDASE; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; FOOT PAD; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IN VIVO STUDY; MOUSE; NONHUMAN; PROMOTER REGION; RAT; REPORTER GENE; REPRESSOR GENE; VERO CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; BETA-GALACTOSIDASE; CARRIER PROTEINS; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED STRAINS; NERVE GROWTH FACTOR; PC12 CELLS; PROMOTER REGIONS (GENETICS); RATS; REPRESSOR PROTEINS; TETRACYCLINE; TOXICITY TESTS; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

ANIMALIA; CYTOMEGALOVIRUS; HERPES; HUMAN HERPESVIRUS 1; MAMMALIA; SIMPLEXVIRUS;

EID: 33646856017     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2006.01.009     Document Type: Article

References (50)

1. Rock D.L., and Fraser N.W. Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J. Virol. 55 (1985) 849-852
2. Latchman D.S. Herpes simplex virus vectors for gene delivery to a variety of different cell types. Curr. Gene Ther. 2 (2002) 415-426
3. Glorioso J.C., Mata M., and Fink D.J. Therapeutic gene transfer to the nervous system using viral vectors. J. Neurovirol. 9 (2003) 165-172
4. Martuza R.L., Malick A., Markert J.M., Ruffner K.L., and Coen D.M. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252 (1991) 854-856
5. Chambers R., et al. Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc. Natl. Acad. Sci. USA 92 (1995) 1411-1415
6. Andreansky S.S., et al. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc. Natl. Acad. Sci. USA 93 (1996) 11313-11318
7. Clackson T. Regulated gene expression systems. Gene Ther. 7 (2000) 120-125
8. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89 (1992) 5547-5551
9. Gossen M., et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268 (1995) 1766-1769
10. No D., Yao T.P., and Evans R.M. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93 (1996) 3346-3351
11. Wang Y., O'MalleyJr B.W., Tsai S.Y., and O'Malley B.W. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91 (1994) 8180-8184
12. Rivera V.M., et al. A humanized system for pharmacologic control of gene expression. Nat. Med. 2 (1996) 1028-1032
13. Pollock R., et al. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc. Natl. Acad. Sci. USA 97 (2000) 13221-13226
14. Paulus W., Baur I., Boyce F.M., Breakefield X.O., and Reeves S.A. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70 (1996) 62-67
15. Lindemann D., Patriquin E., Feng S., and Mulligan R.C. Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol. Med. 3 (1997) 466-476
16. Kafri T., van Praag H., Gage F.H., and Verma I.M. Lentiviral vectors: regulated gene expression. Mol. Ther. 1 (2000) 516-521
17. Ye X., et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283 (1999) 88-91
18. Hofmann A., Nolan G.P., and Blau H.M. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93 (1996) 5185-5190
19. Hwang J.J., Scuric Z., and Anderson W.F. Novel retroviral vector transferring a suicide gene and a selectable marker gene with enhanced gene expression by using a tetracycline-responsive expression system. J. Virol. 70 (1996) 8138-8141
20. Burcin M.M., Schiedner G., Kochanek S., Tsai S.Y., and O'Malley B.W. Adenovirus-mediated regulable target gene expression in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 355-360
21. Vigna E., et al. Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5 (2002) 252-261
22. Herrlinger U., et al. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression. J. Gene Med. 2 (2000) 379-389
23. Urlinger S., et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97 (2000) 7963-7968
24. Schmeisser F., Donohue M., and Weir J.P. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors. Hum. Gene Ther. 13 (2002) 2113-2124
25. Yao F., et al. Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum. Gene Ther. 9 (1998) 1939-1950
26. Stinski M.F., and Roehr T.J. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J. Virol. 55 (1985) 431-441
27. Yao F., and Schaffer P.A. An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1. J. Virol. 69 (1995) 6249-6258
28. Preston C.M., Mabbs R., and Nicholl M.J. Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression. Virology 229 (1997) 228-239
29. Everett R.D., Orr A., and Preston C.M. A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J. 17 (1998) 7161-7169
30. Preston C.M., and Nicholl M.J. Human cytomegalovirus tegument protein pp71 directs long-term gene expression from quiescent herpes simplex virus genomes. J. Virol. 79 (2005) 525-535
31. Gelman I.H., and Silverstein S. Dissection of immediate-early gene promoters from herpes simplex virus: sequences that respond to the virus transcriptional activators. J. Virol. 61 (1987) 3167-3172
32. Mackem S., and Roizman B. Structural features of the herpes simplex virus alpha gene 4, 0, and 27 promoter-regulatory sequences which confer alpha regulation on chimeric thymidine kinase genes. J. Virol. 44 (1982) 939-949
33. Augustinova H., Hoeller D., and Yao F. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice. J. Virol. 78 (2004) 5756-5765
34. Malik A.K., Martinez R., Muncy L., Carmichael E.P., and Weller S.K. Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a LacZ insertion mutant and expression in eukaryotic cells. Virology 190 (1992) 702-715
35. Wu N., Watkins S.C., Schaffer P.A., and DeLuca N.A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70 (1996) 6358-6369
36. Samaniego L.A., Neiderhiser L., and DeLuca N.A. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72 (1998) 3307-3320
37. Lilley C.E., et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75 (2001) 4343-4356
38. Krisky D.M., et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther. 5 (1998) 1593-1603
39. Fotaki M.E., Pink J.R., and Mous J. Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer. Gene Ther. 4 (1997) 901-908
40. Oligino T., et al. Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther. 5 (1995) 491-496
41. Ho D.Y., McLaughlin J.R., and Sapolsky R.M. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system. Brain Res. Mol. Brain Res. 41 (1996) 200-209
42. Wang S., Petravicz J., and Breakefield X.O. Single HSV-amplicon vector mediates drug-induced gene expression via dimerizer system. Mol. Ther. 7 (2003) 790-800
43. Wolfe D., et al. Herpesvirus-mediated systemic delivery of nerve growth factor. Mol. Ther. 3 (2001) 61-69
44. Goss J.R., et al. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51 (2002) 2227-2232
45. Goins W.F., et al. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J. Virol. 68 (1994) 2239-2252
46. Palmer J.A., et al. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral system. J. Virol. 74 (2000) 5604-5618
47. Cai W.Z., and Schaffer P.A. Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J. Virol. 63 (1989) 4579-4589
48. Baradaran K., Dabrowski C.E., and Schaffer P.A. Transcriptional analysis of the region of the herpes simplex virus type 1 genome containing the UL8, UL9, and UL10 genes and identification of a novel delayed-early gene product, OBPC. J. Virol. 68 (1994) 4251-4261
49. Su Y.H., et al. Human corneal cells and other fibroblasts can stimulate the appearance of herpes simplex virus from quiescently infected PC12 cells. J. Virol. 73 (1999) 4171-4180
50. Yao F., and Eriksson E. A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Hum. Gene Ther. 10 (1999) 1811-1818